Publishing research using ab21278? Please let us know so that we can cite the reference in this datasheet.

ab21278 has been referenced in 11 publications.

  • Hedrick ED  et al. Differential PKA activation and AKAP association determines cell fate in cancer cells. J Mol Signal 8:10 (2013). Human . PubMed: 24083380
  • Du LQ  et al. Radiation-sensitising effects of antennapedia proteins (ANTP)-SmacN7 on tumour cells. Int J Mol Sci 14:24087-96 (2013). WB ; Human . PubMed: 24336110
  • Ghadimi MP  et al. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors. Clin Cancer Res 18:2545-57 (2012). WB . PubMed: 22407831
  • Eschenburg G  et al. Smac mimetic LBW242 sensitizes XIAP-overexpressing neuroblastoma cells for TNF-a-independent apoptosis. Cancer Res 72:2645-56 (2012). PubMed: 22491673
  • Kim SH  et al. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 4:897-906 (2011). PubMed: 21411500
  • Courter D  et al. The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways. PLoS One 5:e9633 (2010). WB ; Human . PubMed: 20224789
  • Groskreutz DJ  et al. Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication. Am J Respir Cell Mol Biol 41:189-98 (2009). PubMed: 19131644
  • Ashare A  et al. Insulin-like growth factor-1 improves survival in sepsis via enhanced hepatic bacterial clearance. Am J Respir Crit Care Med 178:149-57 (2008). PubMed: 18436791
  • Benedetti V  et al. Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds. Mol Cancer Ther 7:679-87 (2008). PubMed: 18347153
  • Ashare A  et al. Pseudomonas aeruginosa delays Kupffer cell death via stabilization of the X-chromosome-linked inhibitor of apoptosis protein. J Immunol 179:505-13 (2007). WB ; Human . PubMed: 17579071
  • Rink L  et al. Enhanced phosphorylation of Nbs1, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells. Blood 110:651-60 (2007). PubMed: 17431132

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"